Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Dana-Farber Cancer Institute
Tianjin Medical University Cancer Institute and Hospital
University of Virginia
Merck Sharp & Dohme LLC
West China Hospital
West China Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Insel Gruppe AG, University Hospital Bern
West China Hospital
Centre Antoine Lacassagne
Thomas Jefferson University
Brigham and Women's Hospital
Dana-Farber Cancer Institute
University of Chicago
DEKA Biosciences
Thomas Jefferson University
Eurofarma Laboratorios S.A.
City of Hope Medical Center
Institut du Cancer de Montpellier - Val d'Aurelle
University of Pittsburgh
EpicentRx, Inc.
Institute of Oncology Ljubljana
University of Cincinnati
Case Comprehensive Cancer Center
University of Cincinnati
Austrian South Oncology Group
The Netherlands Cancer Institute
University of Chicago
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
The University of Texas Health Science Center at San Antonio
H. Lee Moffitt Cancer Center and Research Institute
Johannes Gutenberg University Mainz
Abramson Cancer Center at Penn Medicine
Ohio State University Comprehensive Cancer Center
State University of New York - Upstate Medical University
BioMimetix JV, LLC
Cancer Research Antwerp
University of California, San Francisco
University of Cincinnati
UNICANCER
Radiation Therapy Oncology Group
Radiation Therapy Oncology Group
Radiation Therapy Oncology Group
University of Cincinnati
Canadian Cancer Trials Group
Gruppo Oncologico del Nord-Ovest